Company news
Calidi Biotherapeutics, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Calidi Biotherapeutics Announces IL15 Superagonist as First Payload to be Delivered by Systemic Antitumor Virotherapy Platform at AACR Annual Meeting
April 28, 2025
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
April 25, 2025
Calidi Biotherapeutics Announces Chief Executive Officer Transition and Appointment of Eric Poma, Ph.D. as CEO and Director
April 23, 2025
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24
April 22, 2025
Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi’s Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors
June 9, 2024
Decks
The 5 newest of 18 decks. Every deck is listed under its year.
- Investor Presentation (April 2026)
Investor deck · 13 slides · April 2026
- Investor Presentation (February 2026)
Investor deck · 23 slides · Feb 10, 2026
- Investor Presentation (October 2025)
Investor deck · 22 slides · Oct 24, 2025
- Investor Presentation (October 2025)
Investor deck · 22 slides · Oct 22, 2025
- Investor Presentation (August 2025)
Investor deck · 16 slides · August 2025